Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: October 2022 (Specifically October 27, 2022)
Headquarters: Herstal, Belgium
This filing serves to furnish a press release issued by the Company on October 27, 2022, as Exhibit 99.1. The document explicitly states that the information contained in the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The filing text provided does not contain specific financial data. It acts solely as a cover document for an external press release. Consequently, the following metrics are not available in this text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
The filing does not detail specific material changes to financial performance or operations within the text body. It references the issuance of a press release but does not summarize the content of that release regarding material events, acquisitions, or operational shifts.
Guidance, Outlook, and Risks
Management Commentary: The filing includes a signature from Michael McGarrity, Chief Executive Officer, authorizing the report. No specific commentary, guidance, or outlook is provided in the text of the Form 6-K itself.
Risks and Contingencies: No specific risks or contingencies are disclosed in this document text.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated October 27, 2022) to understand the specific material event or announcement triggering this filing.
- Verify if the press release contains updated financial guidance or operational milestones not present in this cover letter.
- Confirm the legal status of the information, noting that the press release content is furnished but not "filed" for liability purposes under Section 18 of the Exchange Act.